Referências

  1. El-Serag HB, Sweet S, Winchester CC, Dent J. (2014). Update on the Epidemiology of Gastro-Oesophageal Reflux Disease: A Systematic Review. Gut, 63(6), 871-880. doi:10.1136/gutjnl-2012-304269.
  2. Eusebi LH, Ratnakumaran R, Yuan Y, et al. (2018). Global Prevalence Of, and Risk Factors For, Gastro-Oesophageal Reflux Symptoms: A Meta-Analysis. Gut, 67(3), 430-440. doi:10.1136/gutjnl-2016-313589.
  3. Iwakiri K, Fujiwara Y, Manabe N, et al. (2022). Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease 2021. Journal of Gastroenterology, 57(4), 267-285. doi:10.1007/s00535-022-01861-z.
  4. Delshad SD, Almario CV, Chey WD, Spiegel BMR. (2020). Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms. Gastroenterology, 158(5), 1250-1261.e2. doi:10.1053/j.gastro.2019.12.014.
  5. Menezes MA, Herbella FAM. (2017). Pathophysiology of Gastroesophageal Reflux Disease. World Journal of Surgery, 41(7), 1666-1671. doi:10.1007/s00268-017-3952-4.
  6. Talley NJ, Zand Irani M. (2021). Optimal Management of Severe Symptomatic Gastroesophageal Reflux Disease. Journal of Internal Medicine, 289(2), 162-178. doi:10.1111/joim.13148.
  7. Gyawali CP, Fass R. (2018). Management of Gastroesophageal Reflux Disease. Gastroenterology, 154(2), 302-318. doi:10.1053/j.gastro.2017.07.049.
  8. Yadlapati R, Gyawali CP, Pandolfino JE. (2022). AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 20(5), 984-994.e1. doi:10.1016/j.cgh.2022.01.025.
  9. Slater BJ, Collings A, Dirks R, et al. (2023). Multi-Society Consensus Conference and Guideline on the Treatment of Gastroesophageal Reflux Disease (GERD). Surgical Endoscopy, 37(2), 781-806. doi:10.1007/s00464-022-09817-3.